亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas

卵泡期 医学 普通外科 内科学
作者
Isabella Albuquerque Pinto Rebello,Vinícius Loures de Oliveira,Luís Felipe Holzwarth Abbud,Tales Aprígio Camargos Ferreira,Ana Paula Aguiar Vidal,Patrícia de Fátima dos Santos Teixeira
出处
期刊:Endocrine-related Cancer [Bioscientifica]
卷期号:31 (2)
标识
DOI:10.1530/erc-23-0185
摘要

Few studies have focused on reclassifying follicular adenomas (FAs) as noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs), but none have been conducted in America or Europe. The aims of this study were to analyze the prevalence of NIFTP reclassified from follicular variant of papillary thyroid carcinomas (FVPTCs) and FAs before NIFTP was defined in the literature, the rate of NIFTP among PTC (papillary thyroid carcinomas) established in real time between 2017 and 2022, and demographic, ultrasonographic, and cytologic characteristics of NIFTPs compared with FVPTCs and FAs. This was a retrospective cohort study of tumors diagnosed as PTCs ( n = 247) and FAs ( n = 144) at a Brazilian hospital. Overall, 13.4% of PTCs and 7% of FAs were reclassified as NIFTPs. The rate of real-time diagnosed NIFTPs among PTC was 12.3%. The median tumor size was larger among NIFTPs (3.0 cm) than FVPTCs (1.1 cm; P < 0.01). A high-risk ultrasonographic pattern was rare in NIFTPs (5.6%). The cytologic classifications differed between FVPTCs and NIFTPs ( P < 0.01), and the most frequent category among NIFTPs was ‘follicular neoplasm’ (52.6%). The category ‘suspicious for malignancy’ was frequent in FVPTCs and rare (5.3%) in NIFTPs. In conclusion, FVPTCs and FAs may be reclassified as NIFTPs. The prevalence of NIFTPs reclassified from FAs was lower in our cohort than in Asian studies. The rate of NIFTPs reclassified from PTC was similar to that of NIFTPs diagnosed in real time and was aligned with rates reported in studies from America and Europe. Preoperative features could not differentiate NIFTPs from FVPTCs or FAs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
欢喜的柚子完成签到,获得积分10
2秒前
3秒前
5秒前
乐乐应助调皮的夏寒采纳,获得10
5秒前
dongguapi发布了新的文献求助10
8秒前
啧啧完成签到,获得积分10
11秒前
Garnieta完成签到,获得积分10
16秒前
suodeheng发布了新的文献求助50
20秒前
叽了咕噜应助黄道婆采纳,获得10
25秒前
Owen应助黄道婆采纳,获得10
25秒前
执着的忆雪完成签到,获得积分10
26秒前
香蕉觅云应助科研通管家采纳,获得10
27秒前
27秒前
完美世界应助科研通管家采纳,获得10
27秒前
32秒前
量子星尘发布了新的文献求助10
34秒前
Ava应助绿色植物采纳,获得10
35秒前
VDC发布了新的文献求助10
37秒前
scc发布了新的文献求助10
39秒前
绿色植物完成签到,获得积分10
54秒前
春天的粥完成签到 ,获得积分10
54秒前
ding应助WAR708采纳,获得10
58秒前
不想干完成签到,获得积分10
1分钟前
一杯沧海完成签到 ,获得积分10
1分钟前
histamin完成签到,获得积分10
1分钟前
瘦瘦大地完成签到,获得积分10
1分钟前
Umair完成签到,获得积分10
1分钟前
王一生完成签到,获得积分10
1分钟前
机灵猕猴桃完成签到 ,获得积分10
1分钟前
1分钟前
悟123完成签到 ,获得积分10
1分钟前
不想干发布了新的文献求助10
1分钟前
1分钟前
叁拾肆完成签到,获得积分10
1分钟前
JamesPei应助VDC采纳,获得10
1分钟前
钦钦发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
Hello应助不想干采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
《药学类医疗服务价格项目立项指南(征求意见稿)》 880
花の香りの秘密―遺伝子情報から機能性まで 800
Stop Talking About Wellbeing: A Pragmatic Approach to Teacher Workload 500
Terminologia Embryologica 500
Silicon in Organic, Organometallic, and Polymer Chemistry 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5616976
求助须知:如何正确求助?哪些是违规求助? 4701321
关于积分的说明 14913294
捐赠科研通 4747476
什么是DOI,文献DOI怎么找? 2549158
邀请新用户注册赠送积分活动 1512299
关于科研通互助平台的介绍 1474049